Trial intelligence / Profile preview

Ziprasidone vs Olanzapine for Acute Mania

2005-004391-21Phase 3Completed

Sponsor
Pfizer
Start
Apr 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in bipolar I disorder comparing Ziprasidone arm with Olanzapine arm (2 arms). Primary endpoint: Primary efficacy endpoint. Started Apr 2006; status: completed.

02

Drugs

ziprasidoneolanzapine
03

Conditions

bipolar I disorder

Beyond the preview

Go deeper on 2005-004391-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-004391-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call